The Antisense and RNAi Therapeutics Treatment market was valued at USD 0.00 in 2023 and is expected to reach USD 0.00 by 2030, growing at a CAGR of 0% (2024-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.

The RNAi Therapeutics market was valued at USD 807.99 Million in 2022 and is expected to reach USD 1,645.76 Million by 2030, growing at a CAGR of 9.3% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.